Literature DB >> 27870235

Efficacy and duration of action of oral fluralaner and spot-on moxidectin/imidacloprid in cats infested with Lynxacarus radovskyi.

Hock Siew Han1, Chiara Noli2, Tiziana Cena3.   

Abstract

BACKGROUND: Lynxacarus radovskyi has been observed in cats in Malaysia; previously treatment with fipronil and moxidectin/imidacloprid spot-on has been described.
OBJECTIVES: To compare the efficacy of two spot-on treatments of moxidectin/imidacloprid, two weeks apart to a single oral dose of fluralaner against Lynxacarus radovskyi and evaluate time to re-infestation.
METHODS: Thirty cats were assigned to three groups of ten cats each. Group 1 received one 250 mg fluralaner tablet. Group 2 received two doses of moxidectin/imidacloprid spot-on two weeks apart. Group 3 consisted of untreated controls. For each cat, three plucks of about 50 hairs each were collected from three sites (dorsal neck, lateral thigh and perineal/tail region) for a total of nine pluckings every two weeks. Severity of infestation was scored from 0 (no parasite), to 1 (only nonhatched eggs), 2 (both hatched and nonhatched eggs), 3 (<50 mites) and 4 (>50 mites). Efficacy was compared between treatment groups and over time in the same group, and results analysed statistically. Re-infestation was defined as the identification of new eggs or mites on hair pluckings.
RESULTS: Moxidectin/imidacloprid spot-on and oral fluralaner achieved 100% eradication within 28 days. No significant difference was observed between groups 1 and 2; re-infestation occurred by Day 56 in both treatment groups.
CONCLUSION: A single dose of oral fluralaner or two moxidectin/imidacloprid spot-on treatments two weeks apart are efficacious in the eradication of L. radovskyi in cats and able to prevent re-infestation for at least 42 days post-treatment.
© 2016 ESVD and ACVD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27870235     DOI: 10.1111/vde.12390

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  5 in total

1.  Association between infestation by Lynxacarus radovskyi (Acari: Lystrophoridae) and the occurrence of Feline Eosinophilic Granuloma Complex.

Authors:  Camilla Matias da Rocha; Priscila Camargo Granadeiro Farias; Leonardo Gorza; Filippe Elias de Freitas Soares; Carolina Magri Ferraz; Ricardo Leandro Oliveira Souza; Lucas Brazolino Siepierski Renon; Fabio Ribeiro Braga
Journal:  J Parasit Dis       Date:  2019-06-11

2.  Oral fluralaner as a treatment for Demodex aurati and Demodex criceti in a golden (Syrian) hamster (Mesocricetus auratus).

Authors:  Gabrielle Brosseau
Journal:  Can Vet J       Date:  2020-02       Impact factor: 1.008

3.  A systematic review of moxidectin as a treatment for parasitic infections in mammalian species.

Authors:  Andrea L Schraven; Hayley J Stannard; Julie M Old
Journal:  Parasitol Res       Date:  2021-02-22       Impact factor: 2.289

4.  Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe.

Authors:  Wilfried Lebon; Massimo Beccati; Patrick Bourdeau; Thomas Brement; Vincent Bruet; Agnieszka Cekiera; Odile Crosaz; Céline Darmon; Jacques Guillot; Marion Mosca; Didier Pin; Jaroslaw Popiel; Dorota Pomorska Handwerker; Diane Larsen; Eric Tielemans; Frédéric Beugnet; Lénaïg Halos
Journal:  Parasit Vectors       Date:  2018-09-10       Impact factor: 3.876

5.  Effectiveness of a fluralaner spot-on formulation in a case of feline demodicosis due to Demodex cati.

Authors:  Pavlina Bouza-Rapti; Anatoli Tachmazidou; Rania Farmaki
Journal:  JFMS Open Rep       Date:  2022-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.